Working with stakeholders across the medical device ecosystem to catalyze the timely, reliable, and cost-effective development of Real-World Evidence to enhance regulatory and clinical decision-making.
NESTcc panel at MDIC Annual Public Forum 2017. Watch the session here.
On February 27, 2019, NESTcc held its second Data Strategy Convening, followed by a NESTcc Network Collaborator meeting […]
NESTcc is pleased to announce that on February 12, 2019, the MDIC Board of Directors confirmed Jennifer Luray, […]
On January 30, 2019, NESTcc convened the first meeting of its Active Surveillance Task Force. This multi-stakeholder group […]
"I am excited by plans for the National Evaluation System for health Technology (NEST), to advance the use of real-world evidence to support regulatory decision-making..." said @US_FDA Acting Commissioner Dr. Ned Sharpless @FDACommissioner of @NESTccMedTech. twitter.com/RAPSorg/status…
FDA CDRH Director Dr. Jeff Shuren calls @NESTccMedTech RWE Test-Cases a "...great example of something that can support both device innovation and device safety." Read more about how FDA is utilizing NESTcc for #medicaldevice safety. twitter.com/MedTechDive/st…
NESTcc Chief of Staff @RachelRRath and Data Network Director @robbert_z recap our 2nd Data Strategy Convening and recent Network Collaborator Meeting. Read more about the importance of these meetings on the strategic and operational priorities of NESTcc: bit.ly/2Um03dP pic.twitter.com/m4kNUyhdjd
Less than a month in, 2019 is shaping up to be another landmark year for the NESTcc. In an effort to further advance our mission to accelerate the development and […]